Simplex Trading
RVPH

Simplex Trading’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

Simplex Trading’s Portfolio RVPH Stock Details RVPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-240
Closed -$1K – 9861
2025
Q3 		$1K Buy
+240
New +$2.04K ﹤0.01% 8870
2025
Q1 		– Sell
-2,695
Closed -$97K – 9504
2024
Q4 		$97K Buy
2,695
+2,610
+3,071% +$72.7K ﹤0.01% 5198
2024
Q3 		$2K Sell
85
-370
-81% -$8.22K ﹤0.01% 8059
2024
Q2 		$11K Sell
455
-305
-40% -$13.9K ﹤0.01% 7382
2024
Q1 		$57K Sell
760
-790
-51% -$62.6K ﹤0.01% 6151
2023
Q4 		$159K Sell
1,550
-30
-2% -$2.69K ﹤0.01% 4908
2023
Q3 		$154K Sell
1,580
-770
-33% -$71.8K ﹤0.01% 4640
2023
Q2 		$275K Buy
2,350
+1,065
+83% +$135K ﹤0.01% 3948
2023
Q1 		$107K Buy
1,285
+525
+69% +$45.8K ﹤0.01% 5077
2022
Q4 		$64K Buy
760
+5
+0.7% +$381 ﹤0.01% 5571
2022
Q3 		$24K Buy
+755
New +$20.9K ﹤0.01% 7335

Other funds holding RVPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's RVPH Position: Q4 2025 in Review

Simplex Trading sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q4 2025, closing a stake of 8,626 shares — an estimated $63K sold.

Simplex Trading first reported a position in RVPH in Q1 2022 and held it in 10 quarters. The position peaked at $232K in Q4 2023. 48 funds tracked by Wall St. Rank hold RVPH as of Q4 2025.

  • Simplex Trading reported no remaining REVIVA PHARMA HLDGS INC position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 8,626 REVIVA PHARMA HLDGS INC shares in Q4 2025, an estimated $63K.
  • Simplex Trading first reported a position in REVIVA PHARMA HLDGS INC in Q1 2022 and held it in 10 quarters.
  • Simplex Trading's REVIVA PHARMA HLDGS INC position peaked at $232K in Q4 2023.
  • 48 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.